Alkido Pharma Inc (AIKI)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current AIKI market cap is 19.03M. The company's latest EPS is USD -4.2810 and P/E is -0.38.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 71k | 963k | 1.01M | 1.37M | 6.17M |
| Operating Income | -9.01M | -3.1M | -5.85M | -2.81M | -2.74M |
| Net Income | -8.66M | -3.54M | -6.92M | -5.44M | -6.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9k | 19k | 0 | 0 | 2.04M |
| Operating Income | -5.69M | -6.53M | -9.44M | -14.35M | -21.8M |
| Net Income | -4.18M | -12.32M | -7.17M | -26.22M | -22.88M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 67.7M | 63.21M | 57.56M | 52.19M | 49.07M |
| Total Liabilities | 5.92M | 4.86M | 4.64M | 4.53M | 6.71M |
| Total Equity | 61.78M | 58.35M | 52.92M | 47.67M | 42.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.28M | 30.5M | 102.66M | 76.24M | 57.56M |
| Total Liabilities | 750k | 877k | 1.06M | 2.47M | 4.64M |
| Total Equity | 10.53M | 29.62M | 101.6M | 73.77M | 52.92M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.91M | -17.49M | -22.23M | -8.59M | -7.19M |
| Investing | -14.72M | -10.36M | -7.17M | 7.72M | 10.15M |
| Financing | -939k | -939k | -939k | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.02M | -4.02M | -6.6M | -10.6M | -22.23M |
| Investing | 1.26M | -24.96M | -8.85M | -14.6M | -7.17M |
| Financing | 1.84M | 31.61M | 78.3M | -7.19M | -939k |
| Market Cap | 19.03M |
| Price to Earnings Ratio | -0.38 |
| Price to Sales Ratio | 4.27 |
| Price to Cash Ratio | 3.08 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 5.35M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.45 (11.31%) |
| Company Name | Alkido Pharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.dominariholdings.com |
| Industry | security brokers & dealers (6211) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
